EUVIMEDEUVIMED entdecken
Leserbrief

From METTL3 PROTACs to pyroptosis-coupled design: a medicinal chemistry agenda for next-generation targeted degraders

M Vijayasimha

Medicinal Chemistry Research · 2026-05 · 35 (5) · 867-870

DOI: 10.1007/s00044-026-03535-4 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Medicinal Chemistry Research, online erschienen am 06.03.2026. Verfasst von M Vijayasimha. Beteiligte Einrichtung: Department of MLT, University Institute of Allied Health Science, Chandigarh University, Mohali, 140413, Punjab, India. vijaya.e19133@cumail.in. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of MLT, University Institute of Allied Health Science, Chandigarh University, Mohali, 140413, Punjab, India. vijaya.e19133@cumail.in.

Zitieren

APA

Vijayasimha, M. (2026). From METTL3 PROTACs to pyroptosis-coupled design: a medicinal chemistry agenda for next-generation targeted degraders. Medicinal Chemistry Research, 35(5), 867-870. https://doi.org/10.1007/s00044-026-03535-4

Vancouver

Vijayasimha M. From METTL3 PROTACs to pyroptosis-coupled design: a medicinal chemistry agenda for next-generation targeted degraders. Medicinal Chemistry Research. 2026;35(5):867-870. doi:10.1007/s00044-026-03535-4

BibTeX
@article{Vijayasimha2026,
  author = {Vijayasimha, M},
  title = {From METTL3 PROTACs to pyroptosis-coupled design: a medicinal chemistry agenda for next-generation targeted degraders},
  journal = {Medicinal Chemistry Research},
  year = {2026},
  volume = {35},
  number = {5},
  pages = {867--870},
  doi = {10.1007/s00044-026-03535-4}
}
Kostenlos starten →